SCHEMBL18952972

SCHEMBL18952972

COC(=O)c1cc2cc(OS(=O)(=O)C(F)(F)F)c(C(=O)O)cc2cc1OS(=O)(=O)C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 2/20 0.42
HPGD P15428 2/20 0.42
HSD11B1 P28845 1/20 0.39
EPAS1 Q99814 1/20 0.37
NPSR1 Q6W5P4 1/20 0.36
CFTR P13569 2/20 0.35
HSD17B10 Q99714 2/20 0.35
SOS1 Q07889 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SDHB P21912 1/20 0.34
LCK P06239 1/20 0.34
FYN P06241 1/20 0.34
CXCR2 P25025 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 2/20 0.34
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18952971 0.96 HSD11B1 (0.41) KDM4EALDH1A1HPGDHSD11B1EPAS1
SCHEMBL16513114 0.88 HSD11B1 (0.50) KDM4EALDH1A1HPGDHSD11B1EPAS1
SCHEMBL31150577 0.87 KDM4E (0.48) KDM4EALDH1A1HPGDHSD11B1EPAS1
SCHEMBL852699 0.87 KDM4E (0.48) KDM4EALDH1A1HPGDHSD11B1EPAS1
SCHEMBL14063330 0.85 HSD11B1 (0.46) KDM4EALDH1A1HSD11B1EPAS1HSD17B10
SCHEMBL17877014 0.85 HSD11B1 (0.43) KDM4EALDH1A1HPGDHSD11B1EPAS1
SCHEMBL17913590 0.84 EPAS1 (0.45) KDM4EHSD11B1EPAS1HSD17B10MEN1
SCHEMBL27229877 0.81 KDM4E (0.41) KDM4EALDH1A1HSD11B1EPAS1CFTR
SCHEMBL7214605 0.80 KDM4E (0.49) KDM4EALDH1A1HPGDHSD11B1EPAS1
SCHEMBL7654198 0.79 RAB9A (0.44) KDM4EALDH1A1HPGDEPAS1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10793668-B2 Naphthoindacenodithiophenes and polymers CLAP CO., LTD. (KR) 2020-10-06 US disclosed
EP-3386989-B1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2019-10-23 EP disclosed
US-20180362704-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2018-12-20 US disclosed
EP-3386989-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2018-10-17 EP disclosed
WO-2017097924-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS BASF SE (DE) 2017-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10793668-B2 Naphthoindacenodithiophenes and polymers RPS21, NR2C2, NR0B2 KDM4E 4743/4885ALDH1A1 1958/4885HPGD 1527/4885
US-20180362704-A1 NAPHTHOINDACENODITHIOPHENES AND POLYMERS RPS21, NR2C2, NR0B2 KDM4E 4743/4885ALDH1A1 1958/4885HPGD 1527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.